The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Long-term survival with glioblastoma multiforme
Abstract
The median survival of glioblastoma patients is approximately 12 months. However, 3-5% of the patients survives for more than 3 years and are referred to as long-term survivors. The clinical and molecular factors that contribute to long-term survival are still unknown. To identify specific parameters that might be associated with this phenomenon, we performed a detailed clinical and molecular analysis of 55 primary glioblastoma long-term survivors recruited at the six clinical centres of the German Glioma Network and one associated centre. An evaluation form was developed and used to document demographic, clinical and treatment-associated parameters. In addition, environmental risk factors, associated diseases and occupational risks were assessed. These patients were characterized by young age at diagnosis and a good initial Karnofsky performance score (KPS). None of the evaluated socioeconomic, environmental and occupational factors were associated with long-term survival. Molecular analyses revealed MGMT hypermethylation in 28 of 36 tumours (74%) investigated. TP53 mutations were found in 9 of 31 tumours (29%) and EGFR amplification in 10 of 38 tumours (26%). Only 2 of 32 tumours (6%) carried combined 1p and 19q deletions. Comparison of these data with results from an independent series of 141 consecutive unselected glioblastoma patients registered in the German Glioma Network revealed significantly more frequent MGMT hypermethylation in the long-term survivor group. Taken together, our findings underline the association of glioblastoma long-term survival with prognostically favourable clinical factors, in particular young age and good initial performance score, as well as MGMT promoter hypermethylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citationMGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Self-citationStummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423 · cited 1×
“Recent data have confirmed that the extent of resection is associated with improved progression-free survival (Stummer et al., 2006).”
BackgroundInactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
Curran, W. J., Scott, C. B., Horton, J., Nelson, J. S., Weinstein, A. S., Fischbach, A. J., Chang, C. H., Rotman, M., Asbell, S. O., Krisch, R. E., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.9.704 · Cited by 1,310
Genetic Pathways to Glioblastoma
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.-L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1337 · Cited by 1,270
The Molecular Basis of Turcot's Syndrome
Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321302 · Cited by 1,133
Fine, H. A., Dear, K. B. G., Loeffler, J. S., Mc Black, P. L., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2585::aid-cncr2820710825>3.0.co;2-s · Cited by 864
Cairncross, G., Berkey, B., Shaw, E., Jenkins, R., Scheithauer, B., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 728
Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N., O'Fallon, J. R., Schaefer, P. L., Scheithauer, B. W., James, C. D., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1246 · Cited by 630
Second Neoplasms after Acute Lymphoblastic Leukemia in Childhood
Neglia, J. P., Meadows, A. T., Robison, L. L., Kim, T. H., Newton, W. A., Ruymann, F. B., Sather, H. N., & Hammond, G. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251902 · Cited by 549
Esteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
Cellular-Telephone Use and Brain Tumors
Inskip, P. D., Tarone, R. E., Hatch, E. E., Wilcosky, T. C., Shapiro, W. R., Selker, R. G., Fine, H. A., Black, P. M., Loeffler, J. S., & Linet, M. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440201 · Cited by 483
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues, P., Schäuble, B., Hausen, A. Z., Estève, J., & Ohgaki, H. (1997) · Europe PMC (PubMed Central) · Cited by 411
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
Burger, P. C., & Green, S. B. (1987) · Cancer · doi:10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x · Cited by 391
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
Chang, S. M. (2005) · JAMA · doi:10.1001/jama.293.5.557 · Cited by 362
Devaux, B. C., O'Fallon, J. R., & Kelly, P. J. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.5.0767 · Cited by 358
Gene expression profiling and genetic markers in glioblastoma survival
Rich, J. N., Hans, C., Jones, B., Iversen, E. S., McLendon, R. E., Rasheed, B. K. A., Dobra, A., Dressman, H. K., Bigner, D. D., Nevins, J. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3936 · Cited by 316
van den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Self-citationFrequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors
Möllemann, M., Wolter, M., Felsberg, J., Collins, V. P., & Reifenberger, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.20575 · Cited by 278
Self-citationEffects of treatment on long‐term survivors with malignant astrocytomas
Imperato, J. P., Paleologos, N. A., & Vick, N. A. (1990) · Annals of Neurology · doi:10.1002/ana.410280614 · Cited by 252
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
Scott, J. N., Rewcastle, N. B., Brasher, P. M. A., Fulton, D. S., MacKinnon, J. A., Hamilton, M. G., Cairncross, J. G., & Forsyth, P. A. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<183::aid-ana7>3.0.co;2-7 · Cited by 250
Schlehofer, B., Blettner, M., Preston-Martin, S., Niehoff, D., Wahrendorf, J., Arslan, A., Ahlbom, A., Choi, W. N., Giles, G. G., Howe, G. R., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2<155::aid-ijc1>3.0.co;2-p · Cited by 242
The Treatment of Glioblastoma Multiforme of the Brain
Jelsma, R., & Bucy, P. C. (1967) · Journal of Neurosurgery · doi:10.3171/jns.1967.27.5.0388 · Cited by 233
Cancer among a Michigan Cohort Exposed to Polybrominated Biphenyls in 1973
Hoque, A., Sigurdson, A. J., Burau, K. D., Humphrey, H. E. B., Hess, K. R., & Sweeney, A. M. (1998) · Epidemiology · doi:10.1097/00001648-199807000-00005 · Cited by 226
Impact of Genotype and Morphology on the Prognosis of Glioblastoma
Schmidt, M. C., Antweiler, S., Urban, N., Mueller, W., Kuklik, A., Meyer-Puttlitz, B., Wiestler, O. D., Louis, D. N., Fimmers, R., & von Deimling, A. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.4.321 · Cited by 211
Self-citationMortality of Aerospace Workers Exposed to Trichloroethylene
Morgan, R. W., Kelsh, M. A., Zhao, K., & Heringer, S. (1998) · Epidemiology · doi:10.1097/00001648-199807000-00013 · Cited by 201
A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999
Chakrabarti, I., Cockburn, M., Cozen, W., Wang, Y., & Preston‐Martin, S. (2005) · Cancer · doi:10.1002/cncr.21539 · Cited by 199
Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma
Homma, T., Fukushima, T., Vaccarella, S., Yonekawa, Y., Di Patre, P. L., Franceschi, S., & Ohgaki, H. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235118.75182.94 · Cited by 195
Glioblastoma Multiforme: A Clinical Survey
Roth, J. G., & Elvidge, A. R. (1960) · Journal of Neurosurgery · doi:10.3171/jns.1960.17.4.0736 · Cited by 180
Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon, R. E., & Halperin, E. C. (2003) · Cancer · doi:10.1002/cncr.11666 · Cited by 176
History of allergies among adults with glioma and controls
Wiemels, J. L., Wiencke, J. K., Sison, J. D., Miike, R., McMillan, A., & Wrensch, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10239 · Cited by 174
Felsberg, J., Erkwoh, A., Sabel, M. C., Kirsch, L., Fimmers, R., Blaschke, B., Schlegel, U., Schramm, J., Wiestler, O. D., & Reifenberger, G. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00044.x · Cited by 173
Self-citationReifenberger, J., Ring, G. U., Gies, U., Ludwig Cobbers, J. M. J., Oberstrab, J., An, H.-X., Niederacher, D., Wechsler, W., & Reifenberger, G. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199607000-00007 · Cited by 172
Self-citationGenetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications
Smith, J. (2000) · Frontiers in Bioscience · doi:10.2741/smith · Cited by 160
Cognitive functioning in long-term survivors of high-grade glioma
Archibald, Y. M., Lunn, D., Ruttan, L., Macdonald, D., Maestro, R. F. D., Barr, H. W. K., Pexman, J. H. W., Fisher, B. J., Gaspar, L. E., & Cairncross, J. G. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.2.0247 · Cited by 157
Ino, Y., Ƶlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Jhung, S., Ramsay, D. A., von Deimling, A., Louis, D. N., & Cairncross, J. G. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.6.0983 · Cited by 151
Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors
von Deimling, A., Fimmers, R., Schmidt, M. C., Bender, B., Faßbender, F., Nagel, J., Jahnke, R., Kaskel, P., Duerr, E., Koopmann, J., et al. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.544 · Cited by 151
Long-Term Survival in Patients with Glioblastoma Multiforme
Chandler, K. L., Prados, M. D., Malec, M. K., & Wilson, C. B. (1993) · Neurosurgery · doi:10.1227/00006123-199305000-00003 · Cited by 149
Prognostic impact of molecular markers in a series of 220 primary glioblastomas
Houillier, C., Lejeune, J., Benouaich‐Amiel, A., Laigle–Donadey, F., Crinière, E., Mokhtari, K., Thillet, J., Delattre, J., Hoang‐Xuan, K., & Sanson, M. (2006) · Cancer · doi:10.1002/cncr.21819 · Cited by 144
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study
He, J., Mokhtari, K., Sanson, M., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.863 · Cited by 142
Lee, M., Wrensch, M., & Miike, R. (1997) · Cancer Causes & Control · doi:10.1023/a:1018470802969 · Cited by 141
Burton, E., Lamborn, K. R., Feuerstein, B. G., Prados, M. D., Scott, J. N., Forsyth, P. A., Passe, S. M., Jenkins, R. B., & Aldape, K. D. (2002) · PubMed · Cited by 137
Recent developments in the use of chemotherapy in brain tumours
van den Bent, M. J., Hegi, M. E., & Stupp, R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.031 · Cited by 123
Burton, E., Lamborn, K. R., Forsyth, P. A., Scott, J. N., O’Campo, J., Uyehara‐Lock, J. H., Prados, M. D., Berger, M. S., Passe, S. M., Uhm, J. H., et al. (2002) · PubMed · Cited by 119
Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors
Kleihues, P., & Ohgaki, H. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800121 · Cited by 119
Molecular genetic alterations in glioblastomas with oligodendroglial component
Kraus, J. A., Lamszus, K., Glesmann, N., Beck, M., Wolter, M., Sabel, M., Krex, D., Klockgether, T., Reifenberger, G., & Schlegel, U. S. (2001) · Acta Neuropathologica · doi:10.1007/s004010000258 · Cited by 115
Self-citationIdentification of expressed genes characterizing long-term survival in malignant glioma patients
Yamanaka, R., Arao, T., Yajima, N., Tsuchiya, N., Homma, J., Tanaka, R., Sano, M., Oide, A., Sekijima, M., & Nishio, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209585 · Cited by 112
Simian virus 40 in human cancers
Vilchez, R. A., Kozinetz, C. A., Arrington, A. S., Madden, C. R., & Butel, J. S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00087-1 · Cited by 109
Ten-year survival among patients with supratentorial astrocytomas grade III and IV
Salford, L. G., Brun, A. E., & Nirfalk, S. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.69.4.0506 · Cited by 108
Influence of p53 mutations on prognosis of patients with glioblastoma
Shiraishi, S., Tada, K., Nakamura, H., Makino, K., Kochi, M., Saya, H., Kuratsu, J., & Ushio, Y. (2002) · Cancer · doi:10.1002/cncr.10677 · Cited by 94
Zhu, A., Shaeffer, J., Leslie, S., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02184-1 · Cited by 94
Étienne-Grimaldi, M.-C., Formento, J. L., Lebrun‐Frénay, C., Gioanni, J., Chatel, M., Paquis, P., Bernard, C., Courdi, A., Bensadoun, R., Pignol, J., et al. (1998) · PubMed · Cited by 92
Association of MutantTP53with Alternative Lengthening of Telomeres and Favorable Prognosis in Glioma
Chen, Y.-J., Hakin-Smith, V., Teo, M., Xinarianos, G., Jellinek, D. A., Carroll, T., McDowell, D., MacFarlane, M. R., Boet, R., Baguley, B. C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0910 · Cited by 90
Barnholtz‐Sloan, J. S., Sloan, A. E., & Schwartz, A. G. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.3.0458 · Cited by 83
Korshunov, A., Голанов, А. В., Sycheva, R., & Pronin, I. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.8.574 · Cited by 81
Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases
Shibamoto, Y., Yamashita, J., Takahashi, M., Yamasaki, T., Kikuchi, H., & Abe, M. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90018-r · Cited by 69
Hiesiger, E. M., Hayes, R. L., Pierz, D. M., et al. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01324695 · Cited by 65
Brat, D. J., Seiferheld, W. F., Perry, A., Hammond, E. H., Murray, K. J., Schulsinger, A., Mehta, M. P., & Curran, W. J. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000231 · Cited by 60
Glioblastoma multiforme with long term survival
Sarkar, C., Deb, P., Sharma, M., Mahapatra, A., & Agarwal, D. (2005) · Neurology India · doi:10.4103/0028-3886.16934 · Cited by 57
Molecular Genetic Analysis of Oligodendroglial Tumors
Hartmann, C. J., Mueller, W. C., Laß, U., Kamel‐Reid, S., & von Deimling, A. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.10 · Cited by 57
Self-citationLong-term survivors of glioblastoma multiforme: clinical and molecular characteristics
Morita, M., Rosenblum, M. K., Bilsky, M. H., Fraser, R. A. R., & Rosenfeld, M. R. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00165483 · Cited by 55
Long-term survival in patients with supratentorial glioblastoma
Salvati, M., Cervoni, L., Artico, M., Caruso, R., & Gagliardi, F. M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1017926603341 · Cited by 51
Rainov, N. G., & Heidecke, V. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000013478.27604.01 · Cited by 51
Vertosick, F. T., & Selker, R. G. (1992) · Surgical Neurology · doi:10.1016/0090-3019(92)90022-f · Cited by 47
Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa.
Zheng, T., Cantor, K. P., Zhang, Y., Chiu, B. C. ‐., & Lynch, C. F. (2001) · PubMed · Cited by 40
Long-term survival after gene therapy for a recurrent glioblastoma
Valery, C. A., Seilhean, D., Boyer, O., Marro, B., Hauw, J., Kémény, J., Marsault, C., Philippon, J. H., & Klatzmann, D. (2002) · Neurology · doi:10.1212/wnl.58.7.1109 · Cited by 32
Cerebral Glioblastomas Can Be Cured!
Bucy, P. C., Oberhill, H. R., Siqueira, E. B., Zimmerman, H. M., & Jelsma, R. K. (1985) · Neurosurgery · doi:10.1227/00006123-198505000-00027 · Cited by 30
Cited by
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Thakkar, J. P., Dolecek, T. A., Horbinski, C., Ostrom, Q. T., Lightner, D. D., Barnholtz-Sloan, J. S., & Villano, J. L. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0275 · Cited by 1,390
A survey of MRI-based medical image analysis for brain tumor studies
Bauer, S., Wiest, R., Nolte, L.-P., & Reyes, M. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/58/13/r97 · Cited by 1,036
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Self-citationMGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Weller, M., Stupp, R., Reifenberger, G., Brandes, A. A., van den Bent, M. J., Wick, W., & Hegi, M. E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.197 · Cited by 778
Self-citationGlioblastoma: pathology, molecular mechanisms and markers
Aldape, K., Zadeh, G., Mansouri, S., Reifenberger, G., & von Deimling, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1432-1 · Cited by 735
Self-citation
Metadata
- Authors
- Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., Weller, M., Schackert, G., & for the German Glioma Network
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 130
- Issue
- 10
- Pages
- 2596-2606
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2151794458
- Cited by
- 887
- References
- 70
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.